A kaleidoscopic view of ovarian genes associated with premature ovarian insufficiency and senescence

Q Yang, S Mumusoglu, Y Qin, Y Sun… - The FASEB …, 2021 - Wiley Online Library
Ovarian infertility and subfertility presenting with premature ovarian insufficiency (POI) and
diminished ovarian reserve are major issues facing the developed world due to the trend of …

Meiotic recombination defects and premature ovarian insufficiency

C Huang, T Guo, Y Qin - Frontiers in Cell and Developmental Biology, 2021 - frontiersin.org
Premature ovarian insufficiency (POI) is the depletion of ovarian function before 40 years of
age due to insufficient oocyte formation or accelerated follicle atresia. Approximately 1–5 …

DNA double-strand break genetic variants in patients with premature ovarian insufficiency

X Ding, X Gong, Y Fan, J Cao, J Zhao, Y Zhang… - Journal of Ovarian …, 2023 - Springer
Premature ovarian insufficiency (POI) is a clinically heterogeneous disease that may
seriously affect the physical and mental health of women of reproductive age. POI primarily …

Primordial germ cell DNA demethylation and development require DNA translesion synthesis

P Shah, R Hill, C Dion, SJ Clark, A Abakir… - Nature …, 2024 - nature.com
Mutations in DNA damage response (DDR) factors are associated with human infertility,
which affects up to 15% of the population. The DDR is required during germ cell …

Research progress of the Fanconi anemia pathway and premature ovarian insufficiency

J Zhao, Y Zhang, W Li, M Yao, C Liu… - Biology of …, 2023 - academic.oup.com
The Fanconi anemia pathway is a key pathway involved in the repair of deoxyribonucleic
acidinterstrand crosslinking damage, which chiefly includes the following four modules …

Spectrum of BRCA1/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study

T Bahsi, HB Erdem - Turkish Journal of Biochemistry, 2020 - degruyter.com
Objectives Hereditary breast and ovarian cancer syndrome is chacterized with multiple
cases of breast cancer and/or ovarian cancer on the same side of the family. BRCA1/BRCA2 …

Novel variants in women with premature ovarian function decline identified via whole-exome sequencing

R Tang, Q Yu - Journal of Assisted Reproduction and Genetics, 2020 - Springer
Purpose To investigate the potential etiologies of premature ovarian insufficiency (POI) and
diminished ovarian reserve (DOR). Methods Fourteen women with sporadic POI and 6 …

Алгоритм молекулярно-генетического обследования для выявления наследственного brca-ассоциированного рака молочной железы

ГП Снигирева, ВА Румянцева… - Альманах …, 2019 - cyberleninka.ru
Актуальность. Около 30% случаев наследственного рака молочной железы (РМЖ)
обусловлено мутациями в генах BRCA1 и BRCA2. Отсутствие в России программ …

A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine capsules for the treatment of premature ovarian insufficiency

X Cao, X Huang, J Liu, F Ma, Y Zeng, C Chen… - Menopause, 2018 - journals.lww.com
Objective: This study was conducted to evaluate the treatment effectiveness of Chinese
herbal medicine capsules containing the Yangyin Shugan formula (YYSG) in premature …

Haploinsufficiency in non-homologous end joining factor 1 induces ovarian dysfunction in humans and mice

G Li, X Yang, L Wang, Y Pan, S Chen… - Journal of Medical …, 2022 - jmg.bmj.com
Background Premature ovarian insufficiency (POI) is a common disease in women that
leads to a reduced reproductive lifespan. The aetiology of POI is genetically heterogeneous …